Craig C. Hopkinson sold $273K of Alkermes (ALKS)

Executed Nov 3 2025, disclosed Nov 3 2025, the same day.

Value, as filed

$273K

9,000 sh × $30.38

Executed

Nov 3 2025

the trade date, as filed

Disclosed

Nov 3 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Craig C. Hopkinson EVP R&D, Chief Medical Officer profile →

Craig C. Hopkinson (EVP R&D, Chief Medical Officer) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Alkermes plc (ALKS). The largest single filing was $437K of ALKS (9,000 sh × $48.58, as filed), executed Aug 3.

The name

ALKS

Alkermes plc ALKS · Healthcare · 32 filings in 24 months ticker →

Healthcare · Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to addres…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Craig C. Hopkinson in ALKS

ALKSSALE Alkermes plc $423K
9,000 sh × $46.99
Exec Sep 1
Filed Sep 1 · 7:08 PM ET ALKSSALE Alkermes plc $437K
9,000 sh × $48.58
Exec Aug 3
Filed Aug 3 · 7:12 PM ET ALKSSALE Alkermes plc $427K
8,300 sh × $51.46
Exec Jul 1
Filed Jul 1 · 6:29 PM ET ALKSSALE Alkermes plc $375K
9,000 sh × $41.67
Exec Jun 1
Filed Jun 1 · 5:30 PM ET ALKSSALE Alkermes plc $301K
9,000 sh × $33.40
Exec May 1
Filed May 1 · 5:30 PM ET ALKSSALE Alkermes plc $320K
9,000 sh × $35.51
Exec Apr 1
Filed Apr 1 · 5:30 PM ET ALKSSALE Alkermes plc $267K
9,000 sh × $29.72
Exec Mar 2
Filed Mar 4 · 5:30 PM ET ALKSSALE Alkermes plc $305K
9,000 sh across 2 lots
Exec Feb 2
Filed Feb 2 · 5:30 PM ET